Starting Your Journey with Paroxysmal Nocturnal Hemoglobinuria (PNH)

If you have just been diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH), it is completely normal to feel overwhelmed. You have likely spent the last few hours or days searching for information about a disease you had never heard of before. PNH is incredibly rare, affecting approximately 1.71 to 2.77 people per million each year ^[1][2]. However, while the name is complex and the condition is rare, the most important thing to know right now is that the “story” of PNH has changed. In the past, this was a difficult disease to manage, but today, with modern treatments, most patients can expect a lifespan similar to that of the general population ^[3][4].

Decoding the Name

The name Paroxysmal Nocturnal Hemoglobinuria was given to the disease over a century ago. While doctors still use it, we now know it is a bit of a misnomer—it doesn’t perfectly describe how the disease works today.

• Paroxysmal: This means “sudden” or “episodic.” While symptoms can flare up (especially during an illness), we now know that the destruction of red blood cells is actually a chronic, constant process ^[5][6].
• Nocturnal: This means “at night.” Historically, patients noticed dark urine in the morning and thought the damage happened while they slept. In reality, red blood cells are being destroyed all day long; the urine just appears darker in the morning because it is more concentrated after a night of sleep ^[5][6].
• Hemoglobinuria: This means “hemoglobin in the urine,” which causes it to look dark (like tea or cola). While this is a classic sign, many patients with PNH never actually see dark urine ^[5].

Understanding the Mechanism: The “Missing Shield”

PNH is an acquired condition, meaning you weren’t born with it. Because it is acquired, you cannot pass this disease to your children ^[7]. It happens because of a random mutation in a single gene (called PIGA) in your bone marrow’s stem cells ^[7][8].

Every person has a complement system—a part of the immune system that acts like a “cleanup crew,” attacking bacteria and damaged cells. Normally, your red blood cells have a “shield” (made of proteins like CD55 and CD59) that tells the complement system, “Don’t attack me; I belong here” ^[9][10].

In PNH, the genetic mutation prevents these shields from sticking to the surface of the cell. Without this protection, your own immune system mistakenly identifies your red blood cells as “invaders” and begins to destroy them. This process is called hemolysis ^[9][6].

Three Stabilizing Facts

When you are in a “panic spiral,” it helps to anchor yourself to the current medical reality of the disease:

1. Life Expectancy is Now Near Normal: For patients receiving modern treatment (complement inhibitors), survival rates are now similar to those of the general population ^[3][11].
2. It is Not Cancer: Although PNH involves a genetic mutation in bone marrow cells, it is not considered a “cancer” in the traditional sense. It is a chronic, manageable blood disorder ^[7].
3. Treatment is Highly Effective: Modern medications like eculizumab, ravulizumab, and pegcetacoplan are designed to specifically block the complement system, stopping the destruction of red blood cells and significantly reducing the risk of complications like blood clots ^[4][12].

Navigating This Guide

Managing PNH today focuses on three goals: stopping the destruction of red blood cells (hemolysis), preventing blood clots (thrombosis), and improving your quality of life ^[4][5]. You will likely work with a hematologist (a blood specialist) who will monitor your disease and help you find the best treatment.

To help you understand your diagnosis, this guide has been divided into several sections: